Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research ...

Moderna will get $54M from a global coalition for a bird flu mRNA vaccine after the US canceled a $760M deal and cut mRNA ...

Aside from maybe high school biology classes, the first time many people heard of mRNA was during the pandemic because of the ...

A team led by Rensselaer Polytechnic Institute (RPI) professors Georges Belfort, Ph.D. (PI), and Pankaj Karande, Ph.D. (co-PI ...

Since the announcements by federal health authorities earlier this year that federal mRNA vaccine funding will be curtailed, ...

Up to $54.3 million CEPI investment aims to help advance Moderna's H5 pandemic influenza vaccine candidate to licensure ...

Old mice experienced "rejuvenation" after receiving this injection. It is an injectable treatment utilizing ribonucleic acid ...

RNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the ...

KAIST researchers have developed a method that attaches DNA fragments to mRNA to slow the onset of protein production, ...

BioNTech has completed its exchange offer to acquire CureVacAcquisition complements BioNTech’s capabilities and proprietary technologies in mRNA ...

NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...

Can the weakened immune systems of older individuals be rejuvenated? Researchers from the German Cancer Research Center (DKFZ ...